Setting future standards for KRAS testing in colorectal cancer.
van Krieken
Han
H
Tol
Jolien
J
D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D004252:DNA Mutational Analysis / Q000592:standards; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D005060:Europe; D006801:Humans; D009154:Mutation; D009362:Neoplasm Metastasis; D011237:Predictive Value of Tests; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D016283:Proto-Oncogene Proteins p21(ras); D011785:Quality Assurance, Health Care; D018631:ras Proteins / Q000235:genetics*
C117307:KRAS protein, human; D011518:Proto-Oncogene Proteins; C512478:EGFR protein, human; D066246:ErbB Receptors; D016283:Proto-Oncogene Proteins p21(ras); D018631:ras Proteins